Scarica l'app Stockscreener
1.0499
0.01%
-0.000100
Precedente Chiudi:
$1.05
Aprire:
$1.02
Volume 24 ore:
179.65K
Relative Volume:
0.03
Capitalizzazione di mercato:
$6.06M
Reddito:
$14.64M
Utile/perdita netta:
$-13.74M
Rapporto P/E:
-0.1444
EPS:
-7.27
Flusso di cassa netto:
$-5.04M
1 W Prestazione:
-12.51%
1M Prestazione:
-61.68%
6M Prestazione:
+77.95%
1 anno Prestazione:
+72.97%
Intervallo 1D:
$1.02
$1.095
Intervallo di 1 settimana:
$1.02
$1.38
Portata 52W:
$0.46
$4.44
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Nome
Novabay Pharmaceuticals Inc
Settore
Industria
Telefono
510-899-8800
Indirizzo
2000 Powell Street, Suite 1150, Emeryville, CA
Confronta NBY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.0404 | 6.31M | 14.64M | -13.74M | -5.04M | -7.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
411.74 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
474.05 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.08 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
816.00 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
316.99 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-09-18 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-07-06 | Reiterato | H.C. Wainwright | Buy |
| 2017-11-15 | Reiterato | Laidlaw | Buy |
| 2017-06-05 | Iniziato | ROTH Capital | Buy |
| 2017-03-27 | Iniziato | Laidlaw | Buy |
| 2017-02-06 | Iniziato | Rodman & Renshaw | Buy |
| 2016-03-07 | Downgrade | Maxim Group | Buy → Hold |
| 2015-12-14 | Reiterato | Maxim Group | Buy |
| 2015-04-30 | Ripresa | Maxim Group | Buy |
| 2013-03-06 | Iniziato | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | Iniziato | Dawson James | Speculative Buy |
Mostra tutto
Novabay Pharmaceuticals Inc Borsa (NBY) Ultime notizie
Custom strategy builders for tracking NovaBay Pharmaceuticals Inc.GDP Growth & Reliable Momentum Entry Alerts - newser.com
Is NovaBay Pharmaceuticals Inc. reversing from oversold territoryWeekly Profit Recap & Safe Entry Trade Reports - newser.com
Statistical indicators supporting NovaBay Pharmaceuticals Inc.’s strength2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Institutional scanner results for NovaBay Pharmaceuticals Inc.Swing Trade & Weekly High Conviction Ideas - newser.com
What technical signals suggest for NovaBay Pharmaceuticals Inc. stockEarnings Recap Report & AI Based Buy and Sell Signals - newser.com
NovaBay Pharmaceuticals Inc. stock trendline breakdown2025 Performance Recap & Free Technical Confirmation Trade Alerts - newser.com
Why NovaBay Pharmaceuticals Inc. stock is popular among millennials2025 Historical Comparison & Risk Controlled Stock Pick Alerts - newser.com
Can NovaBay Pharmaceuticals Inc. recover in the next quarterJuly 2025 Intraday Action & Free AI Powered Buy and Sell Recommendations - newser.com
Is NovaBay Pharmaceuticals Inc. stock attractive for retirement portfoliosJuly 2025 Opening Moves & Safe Entry Point Alerts - newser.com
Can NovaBay Pharmaceuticals Inc. (B9P0) stock beat analyst consensusQuarterly Growth Report & Technical Pattern Recognition Alerts - newser.com
Can NovaBay Pharmaceuticals Inc. stock hit analyst price targetsTrade Risk Assessment & Weekly Stock Performance Updates - newser.com
What institutional flow reveals about NovaBay Pharmaceuticals Inc.Market Sentiment Summary & Weekly Momentum Stock Picks - newser.com
NovaBay Pharmaceuticals CEO David Lazar to resign following stock transfer agreement - Investing.com Canada
Visual analytics tools that track NovaBay Pharmaceuticals Inc. performance2025 Geopolitical Influence & Community Consensus Trade Signals - newser.com
Published on: 2025-10-09 05:27:34 - newser.com
Using flow based indicators on NovaBay Pharmaceuticals Inc.Weekly Earnings Recap & Daily Risk Controlled Trade Plans - newser.com
Reviewing AngioSoma (OTCMKTS:SOAN) and NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) - Defense World
NovaBay Pharmaceuticals Inc Stock Analysis and ForecastPrice Volatility Patterns & Budget Friendly Portfolio Growth - earlytimes.in
Will NovaBay Pharmaceuticals Inc. (B9P0) stock outperform small cap peersMarket Rally & Weekly Market Pulse Updates - newser.com
Is NovaBay Pharmaceuticals Inc. (B9P0) stock cheap by valuation metrics2025 AllTime Highs & Growth Focused Entry Reports - newser.com
How to read the order book for NovaBay Pharmaceuticals Inc.Weekly Volume Report & Weekly Market Pulse Updates - newser.com
What analysts say about NovaBay Pharmaceuticals Inc stockEarnings Miss Alerts & Low Cost Wealth Strategies - earlytimes.in
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
How NovaBay Pharmaceuticals Inc. (B9P0) stock reacts to monetary easingQuarterly Trade Review & High Accuracy Trade Alerts - newser.com
Novabay Pharmaceuticals Inc Azioni (NBY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.39%
1.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):